European Journal Of Molecular And Clinical Medicine Impact Factor
The European Journal of Molecular and Clinical Medicine is a peer-reviewed scientific journal that publishes original research articles, reviews, case reports, and letters to the editor. The journal aims to promote research and knowledge in the field of molecular and clinical medicine, and it covers a wide range of topics including genetics, biochemistry, immunology, pharmacology, and more.
What is Impact Factor?
Impact factor is a metric used to evaluate the importance and influence of a scientific journal. It is calculated by dividing the number of citations received by the journal in a given year by the total number of articles published in the two previous years. The impact factor is widely used by researchers, scientists, and publishers to assess the quality of a journal.
How is Impact Factor Calculated?
The impact factor is calculated by counting the number of citations received by articles published in the journal during a specific period, usually two years. The total number of citations is divided by the total number of articles published in the same period to obtain the impact factor. For example, if a journal published 100 articles in the past two years and received 500 citations during that time, its impact factor would be 5.
European Journal of Molecular and Clinical Medicine Impact Factor
The European Journal of Molecular and Clinical Medicine has been gaining recognition in the scientific community since its inception in 2014. The journal has a current impact factor of 1.326, which is an impressive feat for a relatively new publication. This indicates that the articles published in the journal are being cited by other researchers and are making an impact in the field of molecular and clinical medicine.
Why is Impact Factor Important?
The impact factor is an important metric for scientific journals as it serves as an indicator of the quality and relevance of the research published in the journal. High-impact factor journals are more likely to attract high-quality research and are more likely to be cited by other researchers. This increases the visibility and reputation of the journal, which in turn can lead to more submissions and higher subscription rates.
Conclusion
The European Journal of Molecular and Clinical Medicine has established itself as a reputable publication in the field of molecular and clinical medicine. Its current impact factor of 1.326 is a testament to the quality of the research published in the journal. As the journal continues to grow and attract high-quality research, its impact factor is likely to increase, further solidifying its place as a leading publication in the field.
